Human TCR (MF8) recognizes OR14C36 peptide (FMLYLLTLM) in the context of HLA-A2. Soluble TCR expressed with ZIP-Fos/ZIP-Jun strategy (TRAV-TRAC partial-ZIP-Fos, TRBV-TRBC partial-ZIP-Jun) was validated to be able to bind pMHC in published references. The same expression strategy (ZIP-Fos/ZIP-Jun) is used to express this recombinant Human soluble TCR (MF8). Please note that the activity is not guaranteed.

Specifications

Host Species
Human

Target
OR14C36

Epitope
FMLYLLTLM

MHC
HLA-A2

Clone
MF8

Type
Soluble TCR (ZIP-Fos/ZIP-Jun)

TCR Expression Strategy
ZIP-Fos/ZIP-Jun strategy: the alpha and beta chain (without transmembrane and cytosolic region) can form heterodimer based on ZIP-Fox/ZIP-Jun. The soluble TCR contains variable regions and partial constant regions.

Customer Reviews and Q&As

There are currently no Customer reviews or questions for VS-0622-YF2072. Click the button above to contact us or submit your feedback about this product.